Company intelligence / Profile preview

Invesco

Atlanta, Georgia, USA

Ownership: Private
Employees: ~8489
Development stage: Other

Overview

Invesco is a leading global independent investment management firm dedicated to delivering an investment experience that helps people get more out of life. The company manages a wide array of investment capabilities across all major asset classes, including a significant presence in the healthcare and biotechnology sectors through specialized exchange-traded funds (ETFs) and mutual funds. For a biotech analyst, Invesco is notable for its management of the Invesco Nasdaq Biotechnology ETF (IBBQ) and other healthcare-focused investment vehicles. The firm operates in over 20 countries and serves retail and institutional clients worldwide, providing critical capital and liquidity to the life sciences sector.

Industry: Investors

Beyond the preview

Go deeper on Invesco.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Invesco.

Explore the full profile